GLS-1200 Topical Nasal Spray to Prevent SARS-CoV-2 Infection (COVID-19)
Clinical trial NCT04408183 · TERMINATED
Trial details
- NCT number
- NCT04408183
- Sponsor
- GeneOne Life Science, Inc.
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-06-10
- Primary completion
- 2023-01-10
- Enrollment
- 184
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.